London, UK
David leads Equiteq’s Equity Growth Accelerator (EGA) practice. He works closely with boardrooms and shareholders to drive accelerated growth in revenue, profit, and equity value—enabling clients to reach their valuation targets within a defined timeframe. His portfolio spans a global client base across the consulting industry.
David helps clients unlock rapid, sustainable equity growth. He facilitates equity growth and exit strategy workshops, creating clear route maps to guide firms toward higher valuations in preparation for liquidity events. Beyond planning, he works hands-on with leadership teams to build momentum, ensure execution, and improve performance across the business.
David also leads buyer search mandates and drives the development of Equiteq’s proprietary tools and methodologies. He is the architect of Equiteq’s EGA benchmarking and valuation software, as well as the creator of a global database of 200,000 consulting firms.
David began his career at IBM in the 1970s and 1980s, where he pioneered the implementation of ‘just-in-time’ manufacturing processes. He later became Operations Director at WCI Group, where he was instrumental in scaling the business from $6 million to $100 million over seven years—culminating in a successful sale to Private Equity.
He has launched multiple multi-million-pound consulting businesses, including a £10 million revenue stream from a benchmarking service for the global pharmaceutical sector. To date, he has led over 60 EGA workshops and valuations, and is widely recognized for his insight, precision, and professionalism.
David began his career at IBM in the 1970s and 1980s, where he pioneered the implementation of ‘just-in-time’ manufacturing processes. He later became Operations Director at WCI Group, where he was instrumental in scaling the business from $6 million to $100 million over seven years—culminating in a successful sale to Private Equity.
He has launched multiple multi-million-pound consulting businesses, including a £10 million revenue stream from a benchmarking service for the global pharmaceutical sector. To date, he has led over 60 EGA workshops and valuations, and is widely recognized for his insight, precision, and professionalism.